RxDoctor Payments Data

Courtney Puri

Nurse Practitioner · Toledo, OHNPI 1174233241

Payments from drug & device makers

$2,184in general payments, 2019–2025

Across 104 payments — averaging $21.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$338
  • Novo Nordisk$307
  • AstraZeneca$214
  • Pfizer$160
  • Axsome Therapeutics, Inc.$143
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$143
  • plus $879 from 18 others

What the payments were for

  • Food & beverage$2,184100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,184 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$18,957
Medicare patients
106
Services billed
208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$7,517
JardianceEmpagliflozin11$7,214
Lidocaine23$1,621
Albuterol Sulfate HfaAlbuterol Sulfate63$1,247
Atorvastatin Calcium74$852
Pregabalin18$716
Diclofenac Sodium13$408
Rosuvastatin Calcium18$377
Levothyroxine Sodium42$363
Carvedilol43$355
Hydroxyzine Hcl18$265
Fluticasone Propionate31$255
Nifedipine ErNifedipine14$251
Losartan Potassium27$243
Gabapentin23$242

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$160$7,51713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →